Review
Year 2022,
Volume: 9 Issue: 2, 203 - 214, 31.12.2022
Abstract
References
- 1. Ahn DG., Shin HJ., Kim M., Lee S., Kim HS., Myoung J., Kim V., Kim SJ . (2020 ) Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 28 Mart 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
- 2. Ahn DG., Shin HJ., Kim HM., Lee S., Kim HS., Myoung J., et al .(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
- 3. Ak Ö. (2020). Soğuk Algınlığından Ölümcül Salgına Küresel Kâbus. Bilim ve Teknik Dergisi, 17-27.
- 4. Akbaba M., Kurt B., Nazlıcan E.(2014). Yeni Koronavirüs Salgını. Türk J Public Health. 12(3):217-227.
- 5. Al-Hazmi, A. (2016). Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi Journal of Biological Sciences, 23(4): 507-511.
- 6. Al-Tawfiq JA. (2013). Middle East respiratory syndrome- coronavirus infection: an overview. J Infect Public Health, 6(5):319-22.
- 7. Briggs H. (2020). “Koronavirüs (Covid-19): Binlerce Kişinin Ölümüne Neden Olan Salgının Kaynağı Ne?” https://www.bbc.com/turkce/haberler-dunya-51624167.
- 8. Caly L., Duruce DD., Catton MG., Jans DA., Wagstaff M.(2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, 104787.
- 9. Cascella M., Rajnik M., Cuomo A., Dulebohn SC., Di Napoli R.(2020). Features, Evaluation and Treatment Coronavirus (COVID-19) . StatPearls. Treasure Island (FL): StatPearls Publishing.
- 10. Contini C. , Nuzzo MD. , Barp N. , Bonazza A., Giorgio RD., Tognon M , et al.(2020). Yeni Zoonotik COVID-19 Salgını: Beklenen Küresel Sağlık Endişesi, J Bulaşıcı Geliştirme, 14 (3): 254-264.PMID: 32235085, DOI: 10.3855 / jidc.12671.
- 11. Dae-Gyun A., Hye-Jin S., Mi-Hwa K .L., Hae-Soo K., Jinjong M ., Bum-Tae K et al.(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
Year 2022,
Volume: 9 Issue: 2, 203 - 214, 31.12.2022
Abstract
Objective: The objective of this study is to gain knowledge about a new coronavirus Covis-19 epidemic that threatens public health. Method: “SARS-CoV-2” and “Coronavirus” keywords were searched in the Pubmed, Web of Science and Google Scholar databases and in the Google search engine; relevant articles were studied. Findings: This virus, called SARS-CoV-2, is a subspecies of a large family of viruses. But only seven, including the new virus, can infect human. The coronavirus outbreak that occurred in Wuhan, China, causing the disease called Covid-19, spread to almost all countries of the world, and caused a high number of deaths in a very short time. Conclusion: As of May 2020, there are no antiviral drug that treat the disease. Multidisciplinary studies are important to prevent information pollution about Covid-19 outbreak and to provide correct precaution and treatment. The data obtained from the researches in the wildlife will detect the viruses that may cause possible human and animal epidemics in the future.
Keywords
References
- 1. Ahn DG., Shin HJ., Kim M., Lee S., Kim HS., Myoung J., Kim V., Kim SJ . (2020 ) Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 28 Mart 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
- 2. Ahn DG., Shin HJ., Kim HM., Lee S., Kim HS., Myoung J., et al .(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
- 3. Ak Ö. (2020). Soğuk Algınlığından Ölümcül Salgına Küresel Kâbus. Bilim ve Teknik Dergisi, 17-27.
- 4. Akbaba M., Kurt B., Nazlıcan E.(2014). Yeni Koronavirüs Salgını. Türk J Public Health. 12(3):217-227.
- 5. Al-Hazmi, A. (2016). Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi Journal of Biological Sciences, 23(4): 507-511.
- 6. Al-Tawfiq JA. (2013). Middle East respiratory syndrome- coronavirus infection: an overview. J Infect Public Health, 6(5):319-22.
- 7. Briggs H. (2020). “Koronavirüs (Covid-19): Binlerce Kişinin Ölümüne Neden Olan Salgının Kaynağı Ne?” https://www.bbc.com/turkce/haberler-dunya-51624167.
- 8. Caly L., Duruce DD., Catton MG., Jans DA., Wagstaff M.(2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, 104787.
- 9. Cascella M., Rajnik M., Cuomo A., Dulebohn SC., Di Napoli R.(2020). Features, Evaluation and Treatment Coronavirus (COVID-19) . StatPearls. Treasure Island (FL): StatPearls Publishing.
- 10. Contini C. , Nuzzo MD. , Barp N. , Bonazza A., Giorgio RD., Tognon M , et al.(2020). Yeni Zoonotik COVID-19 Salgını: Beklenen Küresel Sağlık Endişesi, J Bulaşıcı Geliştirme, 14 (3): 254-264.PMID: 32235085, DOI: 10.3855 / jidc.12671.
- 11. Dae-Gyun A., Hye-Jin S., Mi-Hwa K .L., Hae-Soo K., Jinjong M ., Bum-Tae K et al.(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
There are 11 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Environmental Sciences |
| Journal Section | Articles |
| Authors | |
| Publication Date | December 31, 2022 |
| Submission Date | November 5, 2021 |
| Acceptance Date | December 29, 2022 |
| Published in Issue | Year 2022 Volume: 9 Issue: 2 |
